Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$600M |
| 2 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$353M |
| 3 |
Energy Transfer Partners
ET
|
+$350M |
| 4 |
TWX
Time Warner Inc
TWX
|
+$332M |
| 5 |
Financial Select Sector SPDR Fund
XLF
|
+$317M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.19B |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$470M |
| 3 |
KLA
KLAC
|
+$282M |
| 4 |
ITC
ITC HOLDINGS CORP
ITC
|
+$270M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$264M |
Sector Composition
| 1 | Financials | 11.02% |
| 2 | Technology | 9.18% |
| 3 | Energy | 8.61% |
| 4 | Healthcare | 6.6% |
| 5 | Consumer Discretionary | 5.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAGE
3826
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $95K | ﹤0.01% |
28,806
+26,457
| +1,126% | +$87.3K |
|
|
CDI
3827
DELISTED
CDI Corp.
CDI
| $95K | ﹤0.01% |
12,816
-13,423
| -51% | -$99.5K |
|
|
REV
3828
DELISTED
Revlon, Inc.
REV
| $95K | ﹤0.01% |
3,282
+333
| +11% | +$9.64K |
|
3829
Akebia Therapeutics
AKBA
$782M
| $94K | ﹤0.01% |
9,066
+9,041
| +36,164% | +$93.7K |
|
3830
Gladstone Capital
GLAD
$525M
| $94K | ﹤0.01% |
4,994
-1,013
| -17% | -$19.1K |
|
3831
Invesco Global Listed Private Equity ETF
PSP
$334M
| $94K | ﹤0.01% |
1,687
+120
| +8% | +$6.69K |
|
3832
Farmer Brothers
FARM
$39.4M
| $93K | ﹤0.01% |
2,548
+1,830
| +255% | +$66.8K |
|
3833
Fortress Biotech
FBIO
$116M
| $93K | ﹤0.01% |
2,287
+2,100
| +1,123% | +$85.4K |
|
3834
Valhi
VHI
$458M
| $93K | ﹤0.01% |
2,241
+1,716
| +327% | +$71.2K |
|
|
ASXC
3835
DELISTED
Asensus Surgical, Inc.
ASXC
| $93K | ﹤0.01% |
5,500
+4,430
| +414% | +$74.9K |
|
|
SUNS
3836
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
| $93K | ﹤0.01% |
5,667
-1,576
| -22% | -$25.9K |
|
|
DNR
3837
DELISTED
Denbury Resources, Inc.
DNR
| $93K | ﹤0.01% |
25,426
-280,856
| -92% | -$1.03M |
|
|
TVIA
3838
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
| $93K | ﹤0.01% |
81,094
+51,706
| +176% | +$59.3K |
|
3839
iShares Morningstar Small-Cap Value ETF
ISCV
$527M
| $92K | ﹤0.01% |
1,932
+357
| +23% | +$17K |
|
3840
PTC
PTC
$24.6B
| $91K | ﹤0.01% |
1,982
-22,646
| -92% | -$1.04M |
|
|
INOV
3841
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $91K | ﹤0.01% |
8,793
+4,078
| +86% | +$42.2K |
|
3842
PLDT
PHI
$4.22B
| $90K | ﹤0.01% |
3,252
-12
| -0.4% | -$332 |
|
3843
Verint Systems
VRNT
$1.23B
| $90K | ﹤0.01% |
5,039
-534
| -10% | -$9.54K |
|
|
NMRX
3844
DELISTED
Numerex Corp
NMRX
| $90K | ﹤0.01% |
12,171
+11,051
| +987% | +$81.7K |
|
3845
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$329M
| $89K | ﹤0.01% |
6,155
| – | – |
|
|
HABT
3846
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $89K | ﹤0.01% |
5,169
+4,159
| +412% | +$71.6K |
|
3847
Aqua Metals
AQMS
$5.15M
| $88K | ﹤0.01% |
34
+30
| +750% | +$77.6K |
|
3848
iShares MSCI Spain ETF
EWP
$1.4B
| $88K | ﹤0.01% |
3,318
-2,731
| -45% | -$72.4K |
|
3849
CPI Card Group
PMTS
$169M
| $88K | ﹤0.01% |
4,250
+965
| +29% | +$20K |
|
|
RGLS
3850
DELISTED
Regulus Therapeutics
RGLS
| $88K | ﹤0.01% |
325
+132
| +68% | +$35.7K |
|